ABOUT US

To advance the understanding, diagnosis, and treatment of congenital lung malformations through collaborative research, shared expertise, and evidence-based practice, improving outcomes for every child from prenatal detection through long-term follow-up.

 Established in 2023, our group is comprised of clinician-investigators from leading USA-based academic institutions dedicated to improving outcomes for patients with congenital lung malformations.

  Congenital lung malformations are rare, and the clinical decision-making governing their management is complex. We have successfully established a retrospective registry to examine management practices and clinical outcomes relating to CLMs which has paved the way for our new prospective study.